PeptideDB

Hypocrellin A

CAS No.: 77029-83-5

Hypocrellin A is PKC inhibitor, has light-induced antitumor,antifungal and antiviral activities, it also exerts immunomo
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Hypocrellin A is PKC inhibitor, has light-induced antitumor,antifungal and antiviral activities, it also exerts immunomodulatory effects on MHC-restricted presentation of antigen.
In vitro Treatment with Hypocrellin A(HA) resulted in a decrease in cell viability and migration in HCC cells.?Furthermore, ?HA decreased the YAP and TEAD protein levels of the Hippo pathway.?HA could potentiate OA's effect on HCC cells.?HA could inhibit the growth of HCC cells in darkness through Hippo-YAP signaling and HA combined with OA had a better effect than HA or OA alone.
Cell experiments Cells were seeded in 96-well plates at a density of 1*10^4 cells in a final volume of 100 μl and maintained in DMEM medium at 37℃ ?.?After cells were treated with different concentrations of HA (5, 10, 20, 40, 80 μM), 20 μl 5 mg/ml MTT solution were added to each well and incubated for 4 h in the incubator.?Then 150 μl DMSO were added to each well to dissolve the pellet, keep it in the dark for 15 min, and dissolve the crystal completely.?Automatic microplate reader measured at 490 nm optical density (OD value).?The experiment was repeated three times.?For combination test, cells were treated with 20 μM Hypocrellin A?and different?concentrations of OA(25,50,100, 200 μM) .
molecular weight 546.52
Molecular formula C30H26O10
CAS 77029-83-5
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMSO: 2.5 mg/mL (4.57 mM)
References 1. Wang L , Wang J , Cao Y , et al. Molecular evidence for better efficacy of hypocrellin A and oleanolic acid combination in suppression of HCC growth[J]. European Journal of Pharmacology, 2018.